The involvement of TREM2 in the setting of NAFLD/NASH is further supported by the recent demonstration that TREM2 plasma levels positively correlate with NASH severity in humans, pointing to the possible use of TREM2 as a diagnostic marker for patient stratification [57]. Here, TREM2 is linked to metabolic dysfunction-associated steatotic liver disease.